|
|
The Angio-Seal™ Vascular Closure Device
For many patients undergoing cardiovascular catheterization procedures,
significant pain and discomfort is generally experienced with the
post-procedure wound care of the puncture through which the procedure
is performed. Much of this discomfort is associated with the past
standard method of closing the puncture - manual or mechanical
pressure at the puncture site to induce blood clotting. With this
method, the patient is then immobilized anywhere from 4-24 hours
to prevent re-bleeding.
The Angio-Seal™ Vascular Closure Device, originally developed
by Kensey Nash Corporation and exclusively licensed to St. Jude
Medical, Inc., provides a way of closing the puncture and limiting
much of the discomfort associated with this part of a catheterization
procedure, while providing for quicker ambulation and discharge.  The
Angio-Seal™ device consists of three resorbable
components: an anchor, a collagen sponge and a
suture along with a delivery system that closes the puncture. The
anchor and suture act as a pulley to position the collagen into
the puncture tract adjacent to the outside of the artery wall to
seal and close the puncture and effect hemostasis. This easy to
use device has been used to facilitate post-procedure care in over
five million patients since its commercial launch in 1996.
 Angio-Seal™
Vascular Closure Device is exclusively licensed, manufactured,
marketed and distributed by St. Jude Medical, Inc. Angio-Seal® is
a trademark of St. Jude Medical Inc.
|
Overview